Mohammed, C.J.; Xie, Y.; Brewster, P.S.; Ghosh, S.; Dube, P.; Sarsour, T.; Kleinhenz, A.L.; Crawford, E.L.; Malhotra, D.; James, R.W.;
et al. Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease. J. Clin. Med. 2019, 8, 1034.
https://doi.org/10.3390/jcm8071034
AMA Style
Mohammed CJ, Xie Y, Brewster PS, Ghosh S, Dube P, Sarsour T, Kleinhenz AL, Crawford EL, Malhotra D, James RW,
et al. Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease. Journal of Clinical Medicine. 2019; 8(7):1034.
https://doi.org/10.3390/jcm8071034
Chicago/Turabian Style
Mohammed, Chrysan J., Yanmei Xie, Pamela S. Brewster, Subhanwita Ghosh, Prabhatchandra Dube, Tiana Sarsour, Andrew L. Kleinhenz, Erin L. Crawford, Deepak Malhotra, Richard W. James,
and et al. 2019. "Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease" Journal of Clinical Medicine 8, no. 7: 1034.
https://doi.org/10.3390/jcm8071034
APA Style
Mohammed, C. J., Xie, Y., Brewster, P. S., Ghosh, S., Dube, P., Sarsour, T., Kleinhenz, A. L., Crawford, E. L., Malhotra, D., James, R. W., Kalra, P. A., Haller, S. T., & Kennedy, D. J.
(2019). Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease. Journal of Clinical Medicine, 8(7), 1034.
https://doi.org/10.3390/jcm8071034